Endo Pharmaceuticals Solutions Inc. Business Finance Contracts & Agreements
15 Contracts & Agreements
- Assignment Agreements (1 contract)
- Exchange Agreements (1)
- Indenture Agreements (3)
- Note Agreements (2)
- Purchase Agreements (3)
- Security Agreements (1)
- Stock Agreements (3)
- Underwriting Agreements (1)
- FIRST SUPPLEMENTAL INDENTURE (Filed With SEC on March 23, 2009)
- PLEDGE AND SECURITY AGREEMENT MADE BY EACH UNDERSIGNED EQUITYHOLDER TO (Filed With SEC on December 11, 2008)
- INDENTURE dated as of August 26, 2008 (Filed With SEC on December 11, 2008)
- NOTE PURCHASE AGREEMENT dated August 26, 2008 (Filed With SEC on December 11, 2008)
- PURCHASE AND SALE AGREEMENT dated as of August 26, 2008 (Filed With SEC on December 11, 2008)
- ASSET PURCHASE AGREEMENT (Filed With SEC on December 12, 2007)
- INDEVUS PHARMACEUTICALS, INC. 6.25% Convertible Senior Notes due 2009 (Filed With SEC on August 7, 2007)
- OCTREOTIDE CONTINGENT STOCK RIGHTS AGREEMENT by and between INDEVUS PHARMACEUTICALS, INC. (Filed With SEC on April 17, 2007)
- STENT CONTINGENT STOCK RIGHTS AGREEMENT by and between INDEVUS PHARMACEUTICALS, INC. (Filed With SEC on April 17, 2007)
- SUPPRELIN CONTINGENT STOCK RIGHTS AGREEMENT by and between INDEVUS PHARMACEUTICALS, INC. (Filed With SEC on April 17, 2007)
- INDEVUS PHARMACEUTICALS, INC. 7,000,000 Shares Common Stock ($0.001 par valueper Share) UNDERWRITING AGREEMENT (Filed With SEC on June 30, 2006)
- ASSET PURCHASE AGREEMENT (Filed With SEC on December 16, 2005)
- ASSIGNMENT ANDTERMINATION AGREEMENT by and between (Filed With SEC on December 22, 2003)
- CONFIDENTIAL TREATMENT REQUESTED. CONFIDENTIAL PORTIONS OF THIS DOCUMENT HAVE BEEN REDACTED AND HAVE BEEN FILED SEPARATELYWITH THE U.S. SECURITIES AND EXCHANGE COMMISSION... (Filed With SEC on August 13, 2003)
- INDENTURE (Filed With SEC on August 13, 2003)